Vision
A world of simple tests that identify and isolate cancer at its earliest most curable stage.
The goal of the Canary cancer science programs is to develop blood tests and imaging tests that can together be used to detect lethal cancers at a curable stage. Our plan for early and accurate cancer detection involves first screening patients with a blood test and then moving those patients who tested positive to a high-resolution imaging test to further isolate cancer so that it can be removed.
Motivation
Detection of tumors with lethal potential at a stage when they are readily curable would save lives.
Canary Foundation is focused on four cancer types, each of which presents a significant opportunity to save lives and prevent unnecessary treatments through early detection of otherwise lethal disease: cancer of the ovary, pancreas, lung, and prostate. Chances of survival are highest when cancer is detected before it spreads. Thus, accurate detection of cancer that would otherwise be lethal at its earliest stage promises to dramatically improve survival after diagnosis.
Approach
Apply a multi-institutional, collaborative team effort toward blood and imaging biomarker discovery, validation, and translation into diagnostic tests for early detection of lethal cancer.
Canary Foundation has assembled teams of clinical and academic experts from multiple institutions that work collaboratively to realize our vision. They are working together to discover biomarkers uniquely present in people with asymptomatic, very early stage cancer, to validate those biomarkers through rigorous preclinical testing, and ultimately to translate this research into simple diagnostic tests.
 Blood Biomarker |
Discovery Validation Translation |
 Imaging Biomarker |
Copyright © 2008 Canary Foundation. All rights reserved.